Market Size (2019)
—
Vertical: HealthcareBase Year: 2019
Market Size (2019)
—
Projected (2032)
—
CAGR (2019–2032)
N/A
Key Players
10+
This report covers Africa Animal Health Market with forecasts from 2019 to 2032. 10 key companies are profiled.
Africa Animal Health Market is a key focus area for market intelligence and strategic research.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAfrica Animal Health Market
Historical performance and future projections (2020–2030, USD Billion)
INTRODUCTION
The increasing investment, funding, and growing veterinary expenditure across Africa are driving the African animal health market. Furthermore, the rising prevalence of chronic diseases among animals is boosting market growth. Additionally, high cost of animal health products and limited cold chain infrastructure are restraining the growth of the African animal health market. However, rising awareness of animal health and government vaccination programs will provide growth opportunities for the market in the future.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2019
Historical Period
2019 – 2019
Forecast Period
2020 – 2032
Primary Interviews
—
Historical data (2019–2019) and forecast period (2019–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Michael Porter's Five Forces model is a framework to study the Africa animal health market. Strategic business managers trying to gain an edge over competing firms in the Africa animal health market can utilize this model to better comprehend the industry in which the firm operates. The components of each of the forces and the degree of impact of each component in the context of the Africa animal health market have been broken down and analyzed.
PORTER'S FIVE FORCES ANALYSIs: Africa animal health market
Threat of New Entrants
The threat of new entrants in the African animal health market is moderate. While growth opportunities exist, particularly in pharmaceuticals, vaccines, and diagnostics, new players face significant barriers, including high capital investment, compliance with strict regulatory standards, and the challenge of building effective distribution networks. Established companies dominate key segments such as anti-infectives, parasiticides, and diagnostics, benefiting from strong brand recognition and customer loyalty. As a result, while there is potential for new entrants, they must navigate these challenges to successfully compete in a competitive and consolidated market.
BARGAINING POWER OF SUPPLIERS
The bargaining power of suppliers in the African animal health market is high. Many key products rely on specialized raw materials from a limited number of suppliers, particularly for pharmaceuticals, vaccines, and diagnostics. Suppliers also play a key role in product innovation and quality assurance, further strengthening their position. The market’s reliance on a few global suppliers for advanced products gives them significant leverage, though local manufacturing could reduce this dependence over time.
Threat of Substitutes
The threat of substitutes in the African animal health market is moderate. While traditional and alternative remedies are still used in some regions, the increasing focus on scientifically proven treatments, vaccines, and diagnostics is diminishing their appeal. Government regulations and global health standards further limit the viability of substitutes. However, in areas with limited veterinary access or a preference for lower-cost options, substitutes, particularly for feed additives and hygiene products, may still pose a threat.
Bargaining Power of Buyers
The bargaining power of buyers in the African animal health market is moderate. While there are more veterinary options, the high cost of services and products limits buyers' ability to negotiate. Smallholder farmers, especially in rural areas, have less purchasing power, making them sensitive to price changes in products like parasiticides and vaccines. However, the demand for effective, quality solutions in both livestock and companion animal sectors somewhat reduces buyers' bargaining power, as they require specialized products to ensure animal health and productivity.
Intensity of Rivalry
Rivalry in the African animal health market is high. A few dominant players lead the pharmaceutical, vaccine, and diagnostic sectors, constantly innovating and expanding their portfolios to capture market share across both farm and companion animal segments. The demand for high-quality, reliable products fuels fierce competition, particularly in diagnostics and vaccines. However, the rapid market growth, especially in emerging economies, provides opportunities for aggressive expansion, intensifying the competition further.
IMPACT OF COVID-19 on AFRICA ANIMAL HEALTH MARKET
The COVID-19 pandemic had a significant impact on the African animal health market, affecting various aspects of the sector, including supply chains, demand dynamics, and overall market growth. During the initial stages of the pandemic, disruptions to global supply chains led to delays in the importation of essential veterinary products, such as vaccines, pharmaceuticals, and diagnostic tools. These disruptions, coupled with restrictions on transportation and logistics, caused shortages in key markets, particularly in rural and remote regions where access to veterinary services was already limited.
Additionally, the financial strain on many farmers, particularly smallholder operations, led to reduced spending on animal health products and veterinary care. Many farmers faced economic challenges due to disruptions in the agricultural value chain, including market access and reduced income from livestock sales. As a result, there was a slowdown in the purchase of non-essential veterinary products, with farmers prioritizing only critical treatments for their livestock.
On the positive side, the pandemic highlighted the importance of animal health in the broader context of public health and food security, drawing increased attention to the need for effective veterinary care and disease prevention. The rise in zoonotic diseases, which are transmitted from animals to humans, also reinforced the role of veterinary health in controlling the spread of diseases like COVID-19. This led to greater government focus on strengthening veterinary infrastructures and increased funding for animal health programs in certain regions.
The pandemic also accelerated digital transformation within the sector, with the adoption of telemedicine and online platforms for veterinary consultations, diagnostics, and even product distribution. These changes have helped to mitigate some of the disruptions caused by social distancing measures and lockdowns, allowing for continued service delivery and product access in some markets.
In conclusion, while COVID-19 posed significant challenges to the African animal health market through supply chain disruptions, reduced consumer spending, and economic pressures on farmers, it also underscored the essential nature of animal health in public health and food security. The market is expected to recover, with potential long-term shifts toward digital solutions and greater investment in veterinary infrastructure.
Qualitative Overview on General Tender business (NGOs) in Africa Animal Health Market
Non-governmental organizations (NGOs) play a pivotal role in Africa’s animal health sector, particularly in bridging gaps in service delivery, vaccine distribution, and capacity building. Tender processes managed by NGOs are critical for sourcing goods and services, fostering partnerships, and ensuring equitable access to animal health resources.
Digital Tender Platforms The shift towards digital platforms is streamlining the procurement process for NGOs, reducing time and increasing transparency. For example, UNOPS and AfriTender launched a pan-African e-procurement portal in 2023, reducing tender processing time by 50% for NGOs like Mercy Corps. The use of online platforms is growing rapidly, with digital tender submissions in Africa increasing by 25% year-over-year in 2023
Focus on Disease Control and Vaccination Campaigns
NGOs like GALVmed and Heifer International are actively issuing tenders for vaccines, cold-chain equipment, and veterinary supplies to tackle critical animal health challenges. For instance, in 2023, GALVmed partnered with AU-PANVAC to procure 10 million doses of Peste des Petits Ruminants (PPR) vaccines for West Africa.
See plans for professionals or small and medium businesses.

Analytical insights on Africa Animal Health Market covering market dynamics, competitive landscape, and strategic outlook.
Africa Animal Health Market represents a significant market opportunity with multiple growth drivers across regions and segments.
INTRODUCTION
The increasing investment, funding, and growing veterinary expenditure across Africa are driving the African animal health market. Furthermore, the rising prevalence of chronic diseases among animals is boosting market growth. Additionally, high cost of animal health products and limited cold chain infrastructure are restraining the growth of the African animal health market. However, rising awareness of animal health and government vaccination programs will provide growth opportunities for the market in the future.
Increasing Investment and Funding
Increasing investment and funding in the African animal health market is driving significant growth and expansion across the sector. With rising awareness of the importance of animal health in ensuring food security and economic stability, both government and private sector investments are growing. International donors, NGOs, and local governments are providing funding to enhance veterinary infrastructure, improve disease control programs, and promote the use of advanced health technologies such as vaccines, diagnostics, and treatments.
For instance, in June 2024, the Livestock Vaccine Innovation Fund (LVIF) is a seven-year, USD 39.52 million partnership focused on developing and producing innovative vaccines to enhance livestock health and support the livelihoods of smallholder farmers. By addressing key livestock health challenges, the fund aims to improve animal productivity and reduce disease-related losses, ultimately strengthening the economic well-being of farmers, particularly in regions where livestock plays a vital role in food security and income generation.
Moreover, South Africa's Afrigen Biologics has secured a $6.2 million (116 million South African Rand) grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop an mRNA-based vaccine for Rift Valley fever. This funding will support the advancement of the vaccine candidate through preclinical development and Phase I clinical trials, with testing set to occur in South Africa or another outbreak-affected country.
Also, in March 2023, Zoetis received a USD15.3 million grant from the Bill & Melinda Gates Foundation to expand its African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative. The funding used enable Zoetis to extend its reach to seven additional Sub-Saharan African countries and cattle, poultry, and swine. The new five-year initiative, A.L.P.H.A. Plus, is part of Zoetis' long-term sustainability goals, focusing on improving veterinary care, livestock health, and food security in rapidly developing regions.
Additionally, private companies are increasingly entering the market, offering innovative solutions to meet the growing demand for animal healthcare products and services. This influx of capital is not only improving the quality and accessibility of animal health services but also stimulating job creation and fostering sustainable development in the agricultural and livestock sectors across the continent.
GROWING veterinary expenditure ACROSS THE AFRICA
Growing veterinary expenditure across Africa is significantly driving the growth of the continent’s animal health market. As incomes rise and the importance of livestock and companion animals in Africa’s economy increases, pet owners and farmers alike are allocating more resources toward animal healthcare. This includes spending on vaccinations, veterinary services, medicines, and preventive care, all of which contribute to improved animal health and productivity.
Moreover, revenue from Africa’s veterinary sector reached $4.2 billion in 2021 and is projected to more than double to $9.1 billion by 2025. This growth is driven by increased awareness of the importance of animal health and hygiene, along with the growing availability of vaccines and medications for livestock. Governments across the continent are implementing initiatives to improve animal healthcare, and there is a rising trend of traditional African parents encouraging their children to pursue veterinary medicine as a career. Also, in June 2024, the Global Burden of Animal Diseases: Ethiopia Case Study Phase II Closing Stakeholder Workshop highlighted the importance of stakeholder engagement in utilizing GBADs data for lobbying, project proposal development, and shaping policy decisions. This engagement is key to driving investment in animal health and supporting the economic valuation of the livestock sector, showcasing the significant impact of effective disease management on both public health and economic stability.
Further, In the 2025 budget, the Nigerian federal government has allocated USD 1.15 million to enhance animal health, disease prevention, and sustainable livestock management across the country. This funding, directed towards the Federal Ministry of Livestock Development, will support key initiatives outlined in the Economic Recovery and Growth Plan (ERGP), including disease control, vaccination, and capacity building. Notable allocations include USD 0.060 million for needs assessments and disease-free zone protocols, USD 0.015 million for monitoring and evaluation workshops, USD 0.016 million for Public-Private Partnerships (PPP), and USD 0.097 million to equip National Animal Health Crisis Management Centers. Sustained funding and transparent implementation are essential for the success of these initiatives, which aim to tackle critical livestock sector challenges and contribute to economic growth and food security.
With rising awareness of animal welfare, along with increased investment in veterinary care, the demand for animal health products and services is expanding. This growth in veterinary expenditure is creating lucrative opportunities for companies in the animal health industry to introduce innovative solutions, thus fostering the overall development of the market across Africa.
Rising Prevalence of Chronic DISEASES AMONG ANIMALS
The rising prevalence of diseases among animals in Africa, including Brucellosis, Rabies, Newcastle Disease, Marek’s Disease, Foot and Mouth Disease, and various parasitic infections, is significantly impacting the continent’s agricultural and veterinary sectors. For instance, according to the World Health Organization (African Region) in November 2023 that rabies is a viral zoonotic disease caused by the rabies virus (lyssaviruses) that leads to progressive and fatal inflammation of the brain and spinal cord. While both domestic and wild animals can be affected, 99% of rabies cases are attributed to domestic dogs.
According to the Food and Agriculture Organization of the United Nations (2015-2019), Uganda has faced recurring outbreaks of both endemic and emerging animal and human diseases. These include African swine fever (ASF), Peste des Petits Ruminants (PPR), foot and mouth disease (FMD), lumpy skin disease (LSD), sheep and goat pox virus, brucellosis, various hemorrhagic fevers such as Ebola, highly pathogenic avian influenza, Crimean-Congo hemorrhagic fever (CCHF), as well as tick-borne diseases, anthrax, and rabies. Moreover, as per the MRFR analysis, Kenya, similar to other countries in the East Africa region, faces a significant risk of multiple emerging infectious diseases (EIDs) of zoonotic origin, including Rift Valley Fever (RVF), dengue, and yellow fever. Additionally, the country contends with endemic zoonotic diseases such as anthrax, rabies, brucellosis, trypanosomiasis, bovine tuberculosis, cysticercosis, leishmaniasis, echinococcosis, and various transboundary animal diseases. As the incidence of these infections increases, there is a growing demand for advanced animal health products and services, thereby boosting the growth of the Africa animal health market.
The need for vaccines, diagnostic tools, therapeutics, and improved veterinary care is driving market expansion. This surge in disease prevalence, coupled with a heightened focus on animal health, is catalyzing investments in the development and distribution of veterinary products to mitigate the economic and public health risks associated with these diseases.
The rising awareness of animal health across Africa is significantly driving growth in the region's animal health market. As a result of increased education on the importance of disease prevention, proper nutrition, and veterinary care, both livestock owners and pet owners are becoming more proactive in ensuring the well-being of their animals. For instance, • According to the Animal Health Strategy for Africa (2019-2035) offers a comprehensive framework for establishing a sustainable animal health system across the continent, ensuring compliance with World Organisation for Animal Health (OIE) standards and other relevant international guidelines. It sets out a unified vision and objectives aimed at enhancing animal health services in Africa. The strategy is aligned with key global, continental, and regional initiatives, including Agenda 2063, the Sustainable Development Goals (SDGs), the Malabo/Comprehensive African Agricultural Development Program (CAADP), the Global Action Plan on Antimicrobial Resistance, and the Livestock Development Strategy (LiDeSA). • In November 2023, a successful Animal Health Education Awareness Programme was held for livestock farmers in Namibia's Northern Communal Areas (NCA), including regions like Zambezi, Kavango East, and others.
Around 2,800 farmers participated in this training, which focused on enhancing livestock management practices and preventing infectious diseases, especially Transboundary Animal Diseases (TADs). The initiative, organized by Namibia's Directorate of Veterinary Services with support from the WOAH-administered One Health approach project (funded by Germany) and the Ministry of Agriculture, Water, and Land Reform, plays a vital role in strengthening agricultural resilience and disease control in the region, home to 1.16 million cattle and 860,000 sheep and goats. This shift in mindset is fostering higher demand for a range of animal health products, including vaccines, pharmaceuticals, and feed additives. Furthermore, growing concerns about food security and the economic value of livestock, coupled with rising urbanization and the expansion of the middle class, are contributing to a more robust market for animal health solutions. Consequently, this trend presents ample opportunities for key stakeholders, including animal health product manufacturers, distributors, and veterinary service providers, to expand their presence and capitalize on the evolving needs of the African market. Government vaccination programs across Africa are creating significant growth opportunities for the animal health market.
These programs, aimed at controlling and eradicating animal diseases such as foot-and-mouth disease, rabies, and avian influenza, are driving demand for vaccines and related veterinary products. As governments prioritize public health and agricultural resilience, there is an increasing focus on mass vaccination campaigns, particularly in rural and high-risk areas. For instance, • In December 2024, the Kenyan president strongly supported the animal vaccination program, which aims to vaccinate 22 million cattle and 50 million sheep and goats. The Ministry of Agriculture and Livestock Development assured animal owners that the vaccines are safe and locally produced. • July 2023, Promoting One Health—healthy animals, healthy people, and a healthy environment—is central to Veterinarians Without Borders (VWB/VSF) programs. In Africa, where livestock are vital to many communities, ensuring animal health is critical. One major threat is anthrax, a contagious and often fatal zoonotic disease that affects both animals and humans. Vaccinating farm animals is essential to prevent the spread of such diseases, protecting both public health and livelihoods. • April 2023, in Ethiopia's Afar region, a vaccination campaign has successfully protected over two million animals, safeguarding both livestock and the livelihoods of pastoral communities.
Livestock in this area, including camels, cattle, and goats, are vital sources of income and food through sales, meat, and milk. The campaign, which targeted the Oromia, Somali, and Afar regions, aims to prevent disease-related deaths, ensuring the health and resilience of livestock, especially for communities affected by conflict. Community health workers play a key role in driving this initiative, which helps build long-term sustainability in livestock farming and strengthens food security for vulnerable populations. This not only boosts market growth for vaccine manufacturers but also creates opportunities for diagnostic, distribution, and healthcare service providers. With continued support from international organizations and public-private partnerships, government- led vaccination initiatives are poised to enhance animal health outcomes and expand market potential across the continent.
High Cost of Animal Health Products
The high cost of animal health products is a major constraint on the growth of the African animal health market, particularly in a region where many livestock farmers operate on small scales with limited financial resources. Veterinary medicines, vaccines, and other health products are often imported, leading to elevated prices due to import duties, transportation costs, and currency fluctuations. Additionally, the lack of local manufacturing capabilities in many African countries further drives up costs, as reliance on international suppliers increases expenses. For smallholder farmers, who form the backbone of Africa's livestock sector, these high costs are often prohibitive, forcing them to forgo essential treatments or opt for cheaper, lower-quality alternatives. This not only compromises animal health and productivity but also limits the overall demand for quality animal health products. Furthermore, the high costs discourage investment in preventive care, exacerbating disease outbreaks and reducing livestock yields. As a result, the affordability gap stifles market growth, hindering the potential for improved animal health and economic development in the region.
Limited Cold Chain Infrastructure
Limited cold chain infrastructure in Africa is a significant constraint on the growth of the global animal health market on the continent. The lack of efficient and reliable cold storage facilities for vaccines, pharmaceuticals, and other temperature-sensitive products hampers the effective distribution and administration of critical animal health solutions.
For instance, this infrastructure gap leads to significant product losses, reduced vaccine efficacy, and delays in the delivery of essential veterinary medicines, ultimately affecting livestock health and productivity. As animal health solutions require precise temperature control to ensure their effectiveness, the inadequacy of cold chain systems in many African regions limits the potential for growth in the market. This presents both a challenge and an opportunity for stakeholders to invest in and develop robust cold chain infrastructure to unlock the full potential of the African animal health market, improve livestock health outcomes, and support sustainable agricultural practices across the continent.
The rising awareness of animal health across Africa is significantly driving growth in the region's animal health market. As a result of increased education on the importance of disease prevention, proper nutrition, and veterinary care, both livestock owners and pet owners are becoming more proactive in ensuring the well-being of their animals. For instance,
According to the Animal Health Strategy for Africa (2019-2035) offers a comprehensive framework for establishing a sustainable animal health system across the continent, ensuring compliance with World Organisation for Animal Health (OIE) standards and other relevant international guidelines. It sets out a unified vision and objectives aimed at enhancing animal health services in Africa. The strategy is aligned with key global, continental, and regional initiatives, including Agenda 2063, the Sustainable Development Goals (SDGs), the Malabo/Comprehensive African Agricultural Development Program (CAADP), the Global Action Plan on Antimicrobial Resistance, and the Livestock Development Strategy (LiDeSA).
In November 2023, a successful Animal Health Education Awareness Programme was held for livestock farmers in Namibia's Northern Communal Areas (NCA), including regions like Zambezi, Kavango East, and others. Around 2,800 farmers participated in this training, which focused on enhancing livestock management practices and preventing infectious diseases, especially Transboundary Animal Diseases (TADs). The initiative, organized by Namibia's Directorate of Veterinary Services with support from the WOAH-administered One Health approach project (funded by Germany) and the Ministry of Agriculture, Water, and Land Reform, plays a vital role in strengthening agricultural resilience and disease control in the region, home to 1.16 million cattle and 860,000 sheep and goats.
This shift in mindset is fostering higher demand for a range of animal health products, including vaccines, pharmaceuticals, and feed additives. Furthermore, growing concerns about food security and the economic value of livestock, coupled with rising urbanization and the expansion of the middle class, are contributing to a more robust market for animal health solutions. Consequently, this trend presents ample opportunities for key stakeholders, including animal health product manufacturers, distributors, and veterinary service providers, to expand their presence and capitalize on the evolving needs of the African market.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 108 companies operating in the Africa Animal Health Market market, including revenue, employee count, and market positioning where available.
Showing 108 of 108 companies
Virbac
Company Headquarters: Carros, Southeastern France, France Founded: 1968 Workforce: ~4825 Company Working: Virbac develops, manufactures, and markets a wide range of veterinary pharmaceutical products and has a market experience of more than fifty years and is one of the top 10 players in the global animal health market. It operates through the livestock and aquaculture business segments, and manufactures products including parasiticides, immunology, antibiotics/dermatology, specialties, equine, and specialized pet food. The company has a presence in more than 100 countries and generates more than 60% of its revenue from outside Europe. It has 11 manufacturing units in different countries and five fully equipped R&D facilities for the development of products.
Elanco
Company Headquarters: Greenfield, Indiana, United States Founded: 1954 Workforce: 5,800+ Company Working: Elanco develops and markets products related to animal health all over the world. The company operates through five segments, namely, beef, dairy, poultry, swine, and dogs. The company has a strong presence in more than 90 countries and offers more than 125 brands to the customers. The company was a part of the Eli Lilly group, but due to the spinoff of animal health division Elanco became a separate entity and filed IPO registration.
Zoetis
Company Headquarters: Parsippany, New Jersey, United States Founded: 1952 Workforce: 9200+ Company Working: Zoetis is a global animal health company that manufactures, develops, and commercializes pharmaceutical and biological products for animals. It operates through the anti-infectives, vaccines, parasiticides, medicated feed additives, other pharmaceuticals, and other non-pharmaceuticals business segments. It manufactures products for cattle, swine, poultry, fish, and other livestock and companion animals. Zoetis has a wide range of products which provide effective treatment for the animals, and it operates in all the major markets as well as in the developing countries. The company markets more than 200 approved products worldwide.
Boehringer Ingelheim
Boehringer Ingelheim — Healthcare
Vetoquinol
Vetoquinol — Healthcare
Bimeda
3 interactive charts drawn from the Africa Animal Health Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence